Previous terms continue: Approved consistent with the understanding that CDC will continue to coordinate opioid research efforts and outcomes with partners both within HHS and external (SAMHSA, NIH/NIDA, FDA)
Inventory as of this Action
Requested
Previously Approved
02/28/2021
02/28/2021
02/28/2021
6,871
0
6,871
3,093
0
3,093
0
0
0
Conduct an epidemiologic study to assess the real-world client outcomes of three types of Medication Assisted Treatment (MAT) and counseling without medication for individuals with Opioid Use Disorder (OUD). This study will also examine the contextual, provider, and individual factors that influence treatment implementation and client outcomes. This request for change is to add one MSA to the study with no change in burden.
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
Client questionnaire - 24 month follow-up
Non substantial change request Memo OMB 0920-1218 MAT 05-03-19.docx
Attachment 10 IRB Documents 17ACE_MAT.PDF
Treatment Facility Staff Focus Groups